ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag banned substances disease medicine

Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
A pregnant woman gets her blood pressure checked by a doctor
U.K. Health Authority Investigates Epilepsy Drug’s Link to Autism
Peter Hess, Spectrum | Aug 30, 2022 | 3 min read
The Medicines and Healthcare products Regulatory Agency’s investigation comes after a study showed prenatal exposure to topiramate roughly triples a child’s likelihood of having autism or intellectual disability.
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,
Hands-On Power
Mike May | Nov 16, 2003 | 6 min read
Courtesy of Mike Curtis  TAG, YOU'RE SICK! School children learn about communicable diseases with handheld computers and a program called Cooties. In the 1830s, Charles Darwin used a pen and paper to document finches and other fauna and flora in the Galápagos Islands. For the next century and a half, most scientists relied on the same tools to take notes or collect data. Today, Dave Anderson, associate professor of biology at Wake Forest University, follows in Darwin's footsteps--
New Immunoassay Products Let Users Put New Twists On Old Themes
Lisa Seachrist | Sep 29, 1996 | 8 min read
Advanced Chemtech AFfinity Bioreagents Biodesign International Bio-Rad Laboratories BioSource International Boehringer Mannheim Biochemicals Cardinal Associates Inc. Immunochemistry Technologies Peninsula Laboratories Inc. Tropix Inc. Wako Chemicals USA Inc. Wallac Inc. A quick inventory of nearly any molecular biology laboratory these days will turn up a kudzu-like infestation of monoclonal antibodies, fluorescent-tagged secondary antibodies, and immunoassay kits. Immunoassays have become de
Medical Marijuana Debate Moving Toward Closure
Peter Gwynne | Mar 30, 1997 | 9 min read
Sidebar : Two Efforts To Tackle Medical Marijuana Issues A MEDICINAL HERB? NIH may soon be looking into the therapeutic effects of marijuana as consensus grows among scientists that such studies are worth doing. Few areas of science policy are as politicized as the debate over the therapeutic benefits of marijuana. The federal government historically has been reluctant to acknowledge that the drug has medicinal value. Initiatives passed last November in Arizona and California legalizing mariju
Variation in Cannabis Testing Challenges a Young Industry
Katarina Zimmer | Mar 1, 2020 | 10 min read
The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.
How K2 and Other Synthetic Cannabinoids Got Their Start in the Lab
Ashley Yeager | Nov 27, 2018 | 7 min read
Originally intended for basic neuroscience research, the drugs were ultimately hijacked for illicit recreational use.
Obesogens
Kerry Grens | Nov 1, 2015 | 10+ min read
Low doses of environmental chemicals can make animals gain weight. Whether they do the same to humans is a thorny issue.
Cloning Capsized?
Ted Agres | Aug 19, 2001 | 10+ min read
Biopharmaceutical researchers fear how pending federal legislation outlawing the cloning of human cells will restrict their abilities to find cures for major degenerative diseases.1,2 Some also see lawmakers impinging on established nonhuman cloning techniques essential for the discovery of new drugs and therapies. The source of all this worry? The US House of Representatives passed July 31 by a wide margin a bill (H.R. 2505) sponsored by Reps. David Weldon (R-Fla.) and Bart Stupak (D-Mich.) th

Run a Search

ADVERTISEMENT